Medical marijuana may be beneficial for nausea and vomiting, pain and weight loss, but more research is needed to determine potential harms.
Patients with these tumors should be counseled appropriately and offered treatment options for intermediate-risk disease.
PSA doubling time of 6 months or less and seminal vesicle invasion were significant predictors of biochemical recurrence.
In a study, the treatment was used in men who experienced prostate cancer recurrence after primary radiotherapy.
A study of 4,803 patients who underwent robot-assisted radical prostatectomy had long-term outcomes on par with other surgical approaches.
Long-term testosterone therapy in hypogonadal men is safe, an observational study suggests. New cases of prostate cancer were lower than expected.
Most men aged 66 to 79 years receive aggressive treatment even though their life expectancy is less than 10 years.
For Caucasian males, a complete family history of prostate cancer among close and distant relatives may gauge personal risk with greater accuracy.
For decades, prostate cancer risk (PCa) stratification was based primarily on the architectural pattern of the tumor.
New study examined the effect of a U.S. Preventive Services Task Force 2012 recommendation against routine PSA screening.
Prostate cancer (PCa) patients who have the Endo180 protein present in their tumors tend to have a more aggressive form of the disease.
Obese men are at a greater risk of developing more advanced forms of prostate cancer (PCa).
Dual use of both drugs significantly reduced the risk of biochemical prostate cancer recurrence after radical surgery.
Diets rich in walnuts or walnut oils slow prostate cancer (PCa) tumor growth in mice.
Diagnostic usefulness of magnetic resonance imaging/ultrasound (MRI/US) fusion targeted prostate biopsy optimized in PSA level of 5.2 ng/mL or higher.
Scientists have discovered a way to "switch off" prostate cancer (PCa) cell production in mice with a thrice-weekly injection.
Androgen-deprivation therapy (ADT) for more than 1 year is associated with a 2.5 times higher odds of fracture in prostate cancer patients.
Greater PSA increases seen in older men and those with lower baseline testosterone.
Compared with noncarriers, BRCA carriers experience metastatic prostate cancer sooner and have shorter survival.
Guideline outlines use of adjuvant and salvage radiotherapy after surgery for prostate cancer.
AMACR enzyme is being developed to test the potential for prostate cancer drugs.
PSA levels at day 30 found to predict biochemical relapse risk in men with positive surgical margins.
Racial differences in prostate cancer (PCa) treatment regret more pronounced among those without sexual problems.
But overall risk of heart-related death risk from prostate cancer treatment is small, researchers say.
Men who have slept with more than 20 female partners are less likely to develop aggressive prostate cancer (PCa).
Patients who smoke during external beam radiotherapy (EBRT) are at increased risk of distant metastases and dying from prostate cancer.
Consuming ten portions of tomatoes a week can lower the risk of prostate cancer.
Significant association observed for high-risk prostate cancers with no difference according to daily dose.
Vitamin D may be able to suppress inflammation in prostate tissue by boosting expression of the GDF-15 gene.
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)